top of page

Where

Innovation

Meets

Expertise

Pastel Swirl

Patient Support Programs (PSP)

Unlock the power of digital personalization

_edited_edited.jpg
A well-designed PSP can address this challenge and new digital  technologies open up new avenues to effect this

PSPs are increasingly important for pharmaceutical companies to wrap services around the leading-edge therapies; deliver superior patient outcomes and drive market differentiation. 

 

Yet, It is one of the most strictly regulated activities by the industry's codes and regulations e.g. HIPPA, EFPIA, IFPMA and PhRMA Codes, ICH guidelines, data protection, privacy, GDP, quality control process, governance framework, pharmacovigilance, etc.

​

​

Pastel Swirl

Integrated Care Solutions

Tailored integrated care programs designed to provide personalized patient’s one-stop healthcare services (e.g. clinical consultations, medications, diagnostics, financial assistance, home care, education, monitoring, etc.) with person-to-person and technology-supported interactions.

​

Integrated care programs are tailored to connect different stakeholders yet, maximize the value for all participants not just patients

​

​

download2222.png
Pastel Swirl

HCPs Engagement Platform
HCPs engagement is about creating a personalized journey

GettyImages-644984100.jpeg

Take your HCPs engagement to a new dimension

Today, 70 % HCPs are digital natives. Experiences with mobile, social, and digital technologies in their personal lives are shifting their expectations for business interaction; they expect it to be personalized, unique and smooth. Successful customer's engagement is not a one-time activity

​

​

​

Pastel Swirl

Pharmacovigilance & Risk Management Plans

Automation, cognitive technologies, and advanced analytics are providing opportunities to transform pharmacovigilance from the process of preparing AE reports for regulators to creating a learning system that emphasizes benefit/risk management and proactive surveillance throughout the product life cycle.

 

The pharmaceutical industry is set to embrace transformation initiatives at a faster pace  across clinical, regulatory and safety practices. There is  an increased focus on streamlining post-market safety and risk management activities

​

​

​

d41586-020-02673-y_18400070.jpg

Take your PV operations to the next generation operating model

Pastel Swirl

Digital Evidence Generation 

ils8_edited.png

Generating Evidence That Can Make
a Real World Difference

In the digitalized era, evidence generation is driven by the adoption of new technologies that provide solutions for complex challenges. Today, clinical and scientific research can be fully virtual from enrollment, monitoring, assessments & data  enablement through end-to-end digital tools and technology applications.

​

Additionally, outcomes research strategies are essential to  develop evidence and demonstrate the comparative value of your products and to meet the needs of patients, payers, providers and other stakeholders.

​

Tools such as electronic consent, telehealth, remote patient monitoring and electronic clinical-outcome assessments (eCOAs)maintain links to trial participants without in-person visits

​

 

 

 

 

 

 

 

​

​

bottom of page